Salvage surgery following tyrosine kinase inhibitor treatment for advanced non-small cell lung cancer.
Masao KobayashiSoichiro FunakiHideki NagataMitsugi FurukawaEiichi MoriiYasushi ShintaniPublished in: Surgical case reports (2024)
The present patient experienced multiple instances of systemic recurrence after undergoing salvage surgery. Experience with this case indicates that systemic therapy is essential for patients with distant metastatic lung cancer even following salvage surgery for the primary tumor.